BioNTech SE Total Non-Operating Income/Expense 2019-2024 | BNTX

BioNTech SE total non-operating income/expense for the twelve months ending September 30, 2024 was $0.673B, a 172.99% increase year-over-year.

  • BioNTech SE annual total non-operating income/expense for 2023 was $0.536B, a 63.52% increase from 2022.
  • BioNTech SE annual total non-operating income/expense for 2022 was $0.328B, a 216.81% decline from 2021.
  • BioNTech SE annual total non-operating income/expense for 2021 was $-0.281B, a 287.91% increase from 2020.

BioNTech SE Total Non-Operating Income/Expense 2019-2024 | BNTX

  • BioNTech SE annual total non-operating income/expense for 2023 was $0.536B, a 63.52% increase from 2022.
  • BioNTech SE annual total non-operating income/expense for 2022 was $0.328B, a 216.81% decline from 2021.
  • BioNTech SE annual total non-operating income/expense for 2021 was $-0.281B, a 287.91% increase from 2020.